Avastin+ Tecentriq can improve PFS , That means Combinations with avstin or reg. or oter target agents and PD-1/PD-L1 Agents May Improve Outcomes in mCRC
hi ， i’m from china in china， many patients use Iressa，everolimus，Axitinib，Sorafenib as the last line Therapy with mCRC patients use Iressa alternate chemo or other targeted drugs as maintenance therapy ，many people has get stable disease for 2 weeks or more，someone even for a year so，if you have no...
look at this http://link.springer.com/article/10.1245/s10434-013-3449-9/fulltext.html In addition, in our study, pulmonary metastases were present at the time of Lt, or even before Lt in seven patients. Our initial fear was accelerated growth of overlooked metastases when patients were given the con...
XBiotech announced today interim results from its fast-tracked Phase III study being conducted in the US for its anti-cancer agent Xilonix™. Xilonix, a True Human™ monoclonal antibody therapy, is being evaluated in advanced colorectal cancer patients where disease is further complicated with cachexi...